The ICB have decided not to commision a Tirzepatide/Munjaro service in 2026/27.
We have been advised to continue with the service provision for patients already funded under the 2025/26 contract, but advise patients that this will not continue beyond the one year due to the ICB decision to decomsission the service.
As from 1st April 2026 the practice will no longer be starting patients on Munjaro/Tirzepatide or other similar drugs purely for weight loss (but we will consider to continue to prescribe if also need for diabetes)
If any patient would like to complain about this decisoin please email the ICB directly : llricb-llr.Complaints@nhs.net
